Foghorn Therapeutics Inc. (FHTX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $30.91M | +36.8% |
| 2024 | $22.60M | -33.8% |
| 2023 | $34.16M | +77.6% |
| 2022 | $19.23M | +1357.8% |
| 2021 | $1.32M | +206.7% |
| 2020 | $430.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $30.91M | +36.8% |
| 2024 | $22.60M | -33.8% |
| 2023 | $34.16M | +77.6% |
| 2022 | $19.23M | +1357.8% |
| 2021 | $1.32M | +206.7% |
| 2020 | $430.0K | — |